Inogen (INGN) Total Debt Growth (1y) (2014 - 2016)
Inogen (INGN) Total Debt Growth (1y) (2014 - 2016) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 142.67% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | -9.88% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | -1.95% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 1,188.16% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 0.12% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -17.79% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -9.03% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -0.50% |
| 10 | Inogen | 151.86 Mn | 46.32 Mn | 43.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2016 | -79.54% |
| Jun 30, 2016 | -65.88% |
| Mar 31, 2016 | -55.93% |
| Dec 31, 2015 | -48.70% |
| Sep 30, 2015 | -40.58% |
| Jun 30, 2015 | -97.73% |
| Mar 31, 2015 | -94.12% |
| Dec 31, 2014 | -94.23% |